MEIKO ACTIVE M-5900 PCL

Hazard statements (CLP)

H272, H290, H314, H318, H335, H411

Code

Statements

H272

May intensify fire; oxidiser

SECTION 2: Hazards identification

Classification according to GHS

CLP (SI 2019 720 as amended) Oxidising Solids, Category 2 H272 Corrosive to metals, Category 1 H290 Skin corrosion/irritation, Category 1 H314 Serious eye damage/eye irritation, Category 1 H318 Specific target organ toxicity – Single exposure, Category 3, Respiratory H335 tract irritation Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16

Adverse physicochemical, human health and environmental effects

May be corrosive to metals. May intensify fire; oxidiser. May cause respiratory irritation. Causes severe skin burns and eye damage. Toxic to aquatic life with long lasting effects.

2.2 Label elements

Labelling according to GB CLP (SI 2019:720 as amended)

Hazard pictograms

GB CLP) GHS03 GHS05 GHS07 GHS09

Signal word

GB CLP) : Danger

Contains

sodium hydroxide; disodium metasilicate; troclosene sodium

Hazard statements

GB CLP) : H272 - May intensify fire; oxidiser. H290 - May be corrosive to metals. H314 - Causes severe skin burns and eye damage. H335 - May cause respiratory irritation. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

GB CLP) : P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P260 - Do not breathe dust. P273 - Avoid release to the environment. P280 - Wear protective clothing, protective gloves, eye protection, face protection. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water . P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER, a doctor. P390 - Absorb spillage to prevent material damage.

Supplemental label elements

GB CLP) : EUH031 - Contact with acids liberates toxic gas.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with UK REACH Annex XIII Component sodium hydroxide (1310-73-2) This substance/mixture does not meet the PBT criteria of UK REACH regulation, Annex XIII This substance/mixture does not meet the vPvB criteria of UK REACH regulation, Annex XIII disodium metasilicate (6834-92-0) This substance/mixture does not meet the PBT criteria of UK REACH regulation, Annex XIII This substance/mixture does not meet the vPvB criteria of UK REACH regulation, Annex XIII troclosene sodium (2893-78-9) This substance/mixture does not meet the PBT criteria of UK REACH regulation, Annex XIII This substance/mixture does not meet the vPvB criteria of UK REACH regulation, Annex XIII sodium carbonate (497-19-8) This substance/mixture does not meet the PBT criteria of UK REACH regulation, Annex XIII This substance/mixture does not meet the vPvB criteria of UK REACH regulation, Annex XIII Alcohols, C12-13, ethoxylated (66455-14-9) This substance/mixture does not meet the PBT criteria of UK REACH regulation, Annex XIII This substance/mixture does not meet the vPvB criteria of UK REACH regulation, Annex XIII allyl heptanoate (142-19-8) This substance/mixture does not meet the PBT criteria of UK REACH regulation, Annex XIII This substance/mixture does not meet the vPvB criteria of UK REACH regulation, Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP at a concentration equal to or greater than 0,1 % Component sodium hydroxide(1310-73-2) The substance is not included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP disodium metasilicate(6834-92-0) The substance is not included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP troclosene sodium(2893-78-9) The substance is not included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP sodium carbonate(497-19-8) The substance is not included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP Alcohols, C12-13, ethoxylated(66455-14-9) The substance is not included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP allyl heptanoate(142-19-8) The substance is not included in the list established in accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP